Rxwire
In the news · 48h FDA 38 Eli Lilly 19 Roche 10 Merck & Co. (MSD) 10 Johnson & Johnson 5 Daiichi Sankyo 3 AstraZeneca 3 AbbVie 2
Approvals & regulatory · first seen 2h ago, updated 2h ago

FDA starts speedy review of Imfinzi in bladder cancer

1 outlet FDA

FDA starts speedy review of Imfinzi in bladder cancer Phil.Taylor Fri, 25/09/2026 - 11:21

Summary from pharmaphorum.

Coverage 1 article · 1 outlet

  1. pharmaphorum
    FDA starts speedy review of Imfinzi in bladder cancer